BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
Quick Stats
Jan 30, 202655.2
AI Score
HOLD0.53
Volume Ratio
Nov 21, 2025
Next Earnings
10
+ve Days (30d)
18
-ve Days (30d)
BGLC Stock Summary
Last updated Jan 30, 2026
BGLC is currently trading at $2.5968, positioned below its 200-day moving average of $4.41, suggesting bearish momentum. The stock has a 52-week range of $2.0068 to $15.6.
Technical Analysis: The 50-day moving average stands at $3.94, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 20.621, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.257, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BGLC at 55.2/100 with a HOLD recommendation.
BGLC (BioNexus Gene Lab Corp Common stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 20.621 |
| CMF (20) | -0.257 |
| ROC (10) | -29.626 |
| ADX (14) | 33.811 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.388 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -93.93 |
| MFI (14) | 3.836 |
BGLC Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BGLC Price vs Max Options Open Interest
BGLC Max Change In Options Open Interest
BGLC Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BGLC Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BGLC Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BGLC Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BioNexus Gene Lab Corp Common stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BGLC Moving Averages Analysis
BGLC (BioNexus Gene Lab Corp Common stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.02 |
| 20 | 3.44 |
| 30 | 3.65 |
| 50 | 3.94 |
| 100 | 4.57 |
| 200 | 4.41 |
BGLC Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 6.5 million |
| Earnings/Share ($) | -1.28 |
| Net Proft Margin (%) | -0.2427 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |